[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medicenna Therapeutics Corp (MDNA)

Medicenna Therapeutics Corp (MDNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,933
  • Shares Outstanding, K 69,637
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,600 K
  • EBIT $ -10 M
  • EBITDA $ -12 M
  • 60-Month Beta 1.30
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.49
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.14
  • Most Recent Earnings $-0.04 on 07/28/23
  • Next Earnings Date 11/03/23
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate $-0.05
  • Number of Estimates 2
  • High Estimate $-0.04
  • Low Estimate $-0.05
  • Prior Year $-0.05
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1513 +3.77%
on 11/01/23
0.3160 -50.32%
on 10/02/23
-0.1379 (-46.76%)
since 09/29/23
3-Month
0.1513 +3.77%
on 11/01/23
0.4673 -66.40%
on 08/02/23
-0.3023 (-65.82%)
since 08/01/23
52-Week
0.1513 +3.77%
on 11/01/23
0.8388 -81.28%
on 05/02/23
-0.5751 (-78.55%)
since 11/01/22

Most Recent Stories

More News
Could CRISPR Therapeutics Help You Become a Millionaire?

The gene-editing stock still has plenty of promise.

CRSP : 46.73 (+0.41%)
VRTX : 479.00 (+0.34%)
MDNA : 0.1570 (-13.16%)
Medicenna Announces Closing of Public Offering of Units Raising US$20 Million to Advance Pipeline

TORONTO and HOUSTON, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (NASDAQ: MDNA, TSX: MDNA), a clinical...

MDNA.TO : 0.3450 (-1.43%)
MDNA : 0.1570 (-13.16%)
Medicenna Announces Pricing of US$20 Million Public Offering of Units

TORONTO and HOUSTON, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (NASDAQ: MDNA, TSX: MDNA), a clinical...

MDNA.TO : 0.3450 (-1.43%)
MDNA : 0.1570 (-13.16%)
Medicenna Announces the Launch of a Marketed Underwritten Public Offering of Units

TORONTO and HOUSTON, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (Nasdaq: MDNA, TSX: MDNA), a clinical...

MDNA.TO : 0.3450 (-1.43%)
MDNA : 0.1570 (-13.16%)
Medicenna to Announce First Quarter Fiscal 2023 Financial Results and Operational Highlights on Monday, August 15, 2022

TORONTO and HOUSTON, Aug. 05, 2022 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. ("Medicenna" or “the Company") (NASDAQ: MDNA TSX: MDNA), a clinical...

MDNA.TO : 0.3450 (-1.43%)
MDNA : 0.1570 (-13.16%)

Business Summary

Medicenna Therapeutics Corp is a clinical stage immuno-oncology company. It is engaged in developing engineered versions of IL-2, IL4 and IL13 cytokines called Superkines and Empowered Cytokines ECs for the treatment of cancer. Medicenna Therapeutics Corp is based in Toronto, Canada.

See More

Key Turning Points

3rd Resistance Point 0.2361
2nd Resistance Point 0.2180
1st Resistance Point 0.1875
Last Price 0.1570
1st Support Level 0.1389
2nd Support Level 0.1208
3rd Support Level 0.0903

See More

52-Week High 0.8388
Fibonacci 61.8% 0.5762
Fibonacci 50% 0.4951
Fibonacci 38.2% 0.4139
Last Price 0.1570
52-Week Low 0.1513

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.